| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 178.773 | 220.300 | 126.636 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.134 | 3.236 | 5.447 | 1.713 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.134 | 175.538 | 214.852 | 124.922 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.134 | 170.174 | 214.852 | 124.922 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Fischer And Partners S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 178.220 | 178.773 | 356.462 | 354.470 |
| Current Assets | - | - | - | - | - | - | 934 | 327.470 | 189.926 | 76.640 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 167.894 | 184.277 | 74.295 |
| Cash | - | - | - | - | - | - | 934 | 159.575 | 5.649 | 2.345 |
| Shareholders Funds | - | - | - | - | - | - | -730 | 169.442 | 389.279 | 328.780 |
| Social Capital | - | - | - | - | - | - | 404 | 406 | 404 | 402 |
| Debts | - | - | - | - | - | - | 179.884 | 336.801 | 157.108 | 102.331 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6420 - 6420" | |||||||||
| CAEN Financial Year |
6420
|
|||||||||
Comments - Dr. Fischer And Partners S.r.l.